Table 2. View Large | American Society of Hematology

Table 2.

Hemophilia gene and cell therapy programs in late preclinical, IND-enabling, and/or clinical investigations

Hemophilia gene and cell therapy programs in late preclinical, IND-enabling, and/or clinical investigations

This Feature Is Available To Subscribers Only

Sign In or Create an Account